Once they had the right combination, the researchers designed a synthetic gene which codes for a protein that promotes apoptosis, or programmed cell death.

Cancer cells have multiple ways to avoid apoptosis, programmed cell death the means by which organisms deal with defective cells.

A subsequent analysis of the molecule revealed it to be an inhibitor of apoptosis, or programmed cell death.